Clinical Trials Directory

Trials / Completed

CompletedNCT01502215

Transfusion Requirements in Surgical Oncologic Patient

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
198 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Blood transfusion during perioperative period in patients undergoing to major surgery has been associated to several postoperative complications. Particularly in oncologic surgery, red blood cell transfusion has been investigated as a factor of worse outcome and cancer recurrence due to postoperative impairment of cellular immunity. Although red blood cell transfusion has decreased in worldwide clinical practice, this issue still remains a matter of controversy in oncologic surgery. There are no prospective studies comparing outcomes between restrictive or liberal of blood transfusion strategy in oncologic surgery. This study is a prospective and randomized study comparing clinical outcomes between two strategies of transfusion in oncologic surgery - liberal or restrictive

Conditions

Interventions

TypeNameDescription
OTHERRed blood cell transfusionRed blood cell (RBC) transfusion will be given when hemoglobin fall below 9 g/dL since ICU admission until the discharge of intensive care unit. Following administration of the 1 RBC unit, a repeat hemoglobin levels is performed;if a patient's hemoglobin is 9 g/dL or higher, no additional transfusion is necessary.
OTHERRed blood cell transfusionRed blood cell (RBC) transfusion will be only given when hemoglobin fall below 7 g/dL since ICU admission until the discharge of intensive care unit. Following administration of the 1 RBC unit, a repeat hematocrit is performed;if a patient's hemoglobin 7 g/dL or higher, no additional transfusion is necessary

Timeline

Start date
2012-01-01
Primary completion
2012-10-01
Completion
2012-12-01
First posted
2011-12-30
Last updated
2012-12-05

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01502215. Inclusion in this directory is not an endorsement.